The Scientific Programme

Plenary Speakers

The following prestigious experts will give plenary presentations at the congress:

Professor David Heymann, Chairman of the Health Protection Agency
Professor Malcolm Bennett, Professor of Veterinary Pathology, University of Liverpool
Professor Sue Welburn, Director of the Global Health Academy, University of Edinburgh
Dr Mary Hannon-Fletcher, Head of School of Health Sciences, University of Ulster

The Congress will be divided into four concurrent streams. Delegates may attend any presentation in any of the streams at the Congress.

Cellular Pathology

Understanding and diagnosing disease processes by gross pathology, through histopathology and cytology to investigations at the molecular level using the latest technological advances, including:

• Comparative pathology
• Quality assurance measures
• Food animal pathology

Presentations confirmed in the programme include:
Aspects of Diagnostic Pathology; Cytopathology Advantages and Disadvantage; Comparative Cardiac Pathology; and The use of Immunocytochemistry with Special Reference to the TSEs

Microbiology / Infection

Sessions will include identification and antibiotic sensitivity of bacterial pathogens and public health, including:

• Emerging
• Exotic, and
• Endemic
• Microbial Infections

Presentations confirmed in the programme include:
Technological future of bacteriology; Pathogens of marine animals; Unusual anaerobic infections; Brachyspira in livestock

Haematology / Clinical Chemistry [Clinical Pathology]

Assessment of animal health by the sampling of bodily fluids is the basis of the practice of clinical pathology, including:

• Haematology of blood and bone marrow
• Biochemistry including endocrinology of blood, serum, plasma and urine
• exotic animal biochemistry and haematology
• Quality assurance measures

Presentations confirmed in the programme include:
Hypoglycaemia of Birds and Reptiles; Comparative Haematology; Laboratory Animal Haematology; and Reptile Plasma Protein Biochemistry

Pharma Sciences

Sessions to include all aspects of drug discovery and development, including:

• Laboratory animal pathology
• Clinical and pre-clinical studies
• Toxicology
• Biotechnology
• New technologies

Presentations confirmed in the programme include:
Flow Cytometry in Animal and Pharma work; Tissue microarrays or TCR; Developmental and Reproductive Toxicity Regulatory Safety Testing Including Juvenile work; and Quantitative whole body autoradiography in the investigation of tissue distribution of drug related radioactivity